Identifying clinician-related barriers to active surveillance for low-risk prostate cancer in Australia and New Zealand

  • Lawrentschuk, Nathan (Primary Chief Investigator (PCI))
  • Thangasamy, Isaac (Chief Investigator (CI))
  • Ong, Wee Loon (Chief Investigator (CI))
  • Murphy, Declan G. (Chief Investigator (CI))
  • Pritchard, Elizabeth (Chief Investigator (CI))
  • Evans, Susan (Chief Investigator (CI))
  • Millar, Jeremy (Chief Investigator (CI))
  • Chalasani, Venu (Chief Investigator (CI))
  • Rashid, Prem (Chief Investigator (CI))
  • Winter, Matthew W. (Chief Investigator (CI))
  • Vela, Ian (Chief Investigator (CI))
  • Pryor, David (Chief Investigator (CI))
  • Mark, Stephen (Chief Investigator (CI))

Project: Research

Project Details

Project Description

This clinical quality improvement project will build on the body of work already published
from the PCOR-Vic database. It will include a snapshot analysis of the contemporary AS
patterns of care in Australia and New Zealand and a series of clinician (urologists and
radiation oncologists) interviews to identify targetable barriers to improve AS uptake in
Australia and New Zealand.
The specific aims are:
1. To determine the proportion of men eligible for AS as captured in PCOR-ANZ who
were placed on AS, and factors associated with it
2. To determine the proportion of men on AS as captured in PCOR-ANZ, who had
subsequent active treatment within 12 months of diagnosis, and factors associated
with it
3. To identify clinician-related barriers to and recommendations for the effective
utilisation of AS in eligible men.
Effective start/end date4/09/193/09/21


  • prostate cancer